Kymera Therapeutics, Inc. ($KYMR)
Filing Information
| Accession Number | 0001193125-26-283139 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 25, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
15,000
Total Value
$675,250.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Business Officer | Common Stock | โ | Jun 25, 2026 | Exercise/Conversion | 5,000 | $21.05 | $105,250.00 | 55,195 | Direct | โ | View Details | |
Chief Business Officer | Common Stock | โ | Jun 25, 2026 | Sale | 2,500 | $109.00 | $272,500.00 | 52,695 | Direct | โ | View Details | |
Chief Business Officer | Common Stock | โ | Jun 25, 2026 | Sale | 2,500 | $119.00 | $297,500.00 | 50,195 | Direct | โ | View Details | |
Chief Business Officer | Stock Option (Right to Buy) | Derivative | Jun 25, 2026 | Exercise/Conversion | 5,000 | $0.00 | $0.00 | 90,000 | Direct | โ | View Details |